title: [Medium-long term treatment with infliximab and methotrexate in posterior and/or chronic uveitis refractory to conventional treatment].
authors.forename: Tatiana
authors.initials: T
authors.lastname: Cobo-Ibáñez
authors.forename: Santiago
authors.initials: S
authors.lastname: Muñoz-Fernández
authors.forename: Ventura
authors.initials: V
authors.lastname: Hidalgo-Barrero
authors.forename: Emilio
authors.initials: E
authors.lastname: Martín-Mola
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha; D014605:Uveitis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D008727:Methotrexate